Integrated Filing — IndAS

General information about company
Scrip Code	544319
NSE Symbol	SENORES
MSEI Symbol	NA
ISIN	INE0RB801010
Name of company	SENORES PHARMACEUTICALS LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	15-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	09-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Consolidated
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Pharmaceuticals
Start date and time of board meeting	15-May-2025   12:30:00
End date and time of board meeting	15-May-2025   17:00:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	1142100000	3982500000
	Other income	117700000	192600000
	Total income	1259800000	4175100000
2	Expenses
(a)	Cost of materials consumed	209400000	916400000
(b)	Purchases of stock-in-trade	290600000	898200000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	74600000	-7600000
(d)	Employee benefit expense	146300000	603700000
(e)	Finance costs	53000000	215500000
(f)	Depreciation, depletion and amortisation expense	52300000	168400000
(f)	Other Expenses
1	Other Expenses	226800000	674800000
	Total other expenses	226800000	674800000
	Total expenses	1053000000	3469400000
3	Total profit before exceptional items and tax	206800000	705700000
4	Exceptional items	0	0
5	Total profit before tax	206800000	705700000
6	Tax expense
7	Current tax	67300000	155600000
8	Deferred tax	-40200000	-33300000
9	Total tax expenses	27100000	122300000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	179700000	583400000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	179700000	583400000
17	Other comprehensive income net of taxes	-1200000	-35300000
18	Total Comprehensive Income for the period	178500000	548100000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	460500000	460500000
	Face value of equity share capital	10	10
27	Details of debt securities
22	Reserves excluding revaluation reserve		100000000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	3.81	16.12
	Diluted earnings (loss) per share from continuing operations	3.81	16.12
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	3.81	16.12
	Diluted earnings (loss) per share from continuing and discontinued operations	3.81	16.12
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Consolidated
	Assets
1	Non-current assets
	Property, plant and equipment	1988500000
	Capital work-in-progress	441700000
	Investment property	0
	Goodwill	382100000
	Other intangible assets	542700000
	Intangible assets under development	1283300000
	Biological assets other than bearer plants	93600000
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	100000
	Trade receivables, non-current	0
	Loans, non-current	0
	Other non-current financial assets	51800000
	Total non-current financial assets	51900000
	Deferred tax assets (net)	186700000
	Other non-current assets	73800000
	Total non-current assets	5044300000
2	Current assets
	Inventories	566300000
	Current financial asset
	Current investments	0
	Trade receivables, current	1238800000
	Cash and cash equivalents	1053800000
	Bank balance other than cash and cash equivalents	2801200000
	Loans, current	0
	Other current financial assets	1169700000
	Total current financial assets	6263500000
	Current tax assets (net)
	Other current assets	394500000
	Total current assets	7224300000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	12268600000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	460500000
	Other equity	7401300000
	Total equity attributable to owners of parent	7861800000
	Non controlling interest	260600000
	Total equity	8122400000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	1624600000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	82000000
	Total non-current financial liabilities	1706600000
	Provisions, non-current	32600000
	Deferred tax liabilities (net)	0
	Deferred government grants, Non-current	0
	Other non-current liabilities	0
	Total non-current liabilities	1739200000
	Current liabilities
	Current financial liabilities
	Borrowings, current	1423000000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	155000000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	517200000
	Total Trade payable	672200000
	Other current financial liabilities	96000000
	Total current financial liabilities	2191200000
	Other current liabilities	60300000
	Provisions, current	20600000
	Current tax liabilities (Net)	134900000
	Deferred government grants, Current
	Total current liabilities	2407000000
3	Liabilities directly associated with assets in disposal group classified as held for sale
4	Regulatory deferral account credit balances and related deferred tax liability
	Total liabilities	4146200000
	Total equity and liabilites	12268600000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Consolidated	Consolidated
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
	Total Amount of items that will not be reclassified to profit and loss
2	Income tax relating to items that will not be reclassified to profit or loss
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss	1200000	35300000
5	Total Other comprehensive income	-1200000	-35300000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Consolidated
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			705700000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			0
	Adjustments for decrease (increase) in inventories			-192600000
	Adjustments for decrease (increase) in trade receivables, current			-118800000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			-223900000
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			-40100000
	Adjustments for other financial assets, current			-348200000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			-457900000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			9800000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			168400000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			0
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			27400000
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			0
	Adjustments for dividend income			0
	Adjustments for interest income			0
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			0
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			0
	Other adjustments to reconcile profit (loss)			0
	Other adjustments for non-cash items			-29300000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			-1205200000
	Net cash flows from (used in) operations			-499500000
	Dividends received			0
	Interest paid			-203600000
	Interest received			-71600000
	Income taxes paid (refund)			91700000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			-459200000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			36900000
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			0
	Purchase of property, plant and equipment			1575200000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			3300000
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			2757600000
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			71600000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) investing activities	-4294800000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			4717600000
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			1210100000
	Repayments of borrowings			0
	Payments of lease liabilities			-7300000
	Dividends paid			0
	Interest paid			203600000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			5731400000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			977400000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			977400000
	Cash and cash equivalents cash flow statement at beginning of period			76500000
	Cash and cash equivalents cash flow statement at end of period			1053900000